FDA Funding Debate Reframed By GAO Reports On Strategic Planning
This article was originally published in The Gray Sheet
Executive Summary
Republican senators argue that new Government Accountability Office reports critical of FDA's efforts to track its strategic plan and regulatory science progress show that that agency needs significant reform.